IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Rydex Biotechnology A

CUSIP: 78355E353 | 1 institutional holders

Quarters

Q4 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2023

Livelsberger Financial Advisory52,948
3.0% of portfolio›$3.4M
StyleTurnoverLocationFiled
Livelsberger Financial Advisory
52,948$3.4M3.0%YieldVery LowAshland, OH2024-03-22